The Centers for Medicare & Medicaid Services’ Medicaid fiscal accountability proposed rule and recent block grant guidance “could have fiscal and credit repercussions” for states and health care providers, especially nonprofit providers with “higher Medicaid exposure,” according to a recent commentary by Fitch Ratings.

Fitch considers the Medicaid fiscal accountability proposed rule potentially more disruptive to credit quality, citing an AHA analysis conducted with Manatt Health that found hospitals alone could see reductions in Medicaid payments of $23 billion to $31 billion annually under the rule. 

AHA has urged CMS to withdraw the proposed rule because it “would severely curtail the availability of health care services to millions of individuals” and “many of its provisions are not legally permissible.”

CMS’s block grant guidance, which the House of Representatives denounced last week in a non-binding resolution, provides an option for states to apply for 1115 waiver authority to receive a defined amount of federal funding to cover services for certain healthy adults, among other provisions. 
 

Related News Articles

Headline
The White House Office of Management and Budget Jan. 29 rescinded a memo it issued two days earlier directing federal agencies to temporarily pause federal…
Headline
The White House Office of Management and Budget late Jan. 27 issued a memo directing federal agencies to temporarily pause federal grants, loans and other…
Headline
The Centers for Medicare & Medicaid Services Dec. 4 announced that drug manufacturers bluebird bio, inc. (manufacturer of Lyfgenia) and Vertex…
Headline
The Centers for Medicare & Medicaid Services Oct. 16 approved section 1115 demonstration amendments which will allow Medicaid and Children's Health…
Headline
The Centers for Medicare & Medicaid Services Sept. 26 released guidance on state compliance with the Early and Periodic Screening, Diagnostic and Treatment…
Headline
The Centers for Medicare & Medicaid Services Aug. 15 released a state funding notice for the Cell and Gene Therapy Access Model. The CGT Access Model will…